Search

DoD Awards Morphotek $2.3M to Develop Biowarfare Therapies

Morphotek, Inc., a subsidiary of Japanese pharmaceutical company Eisai Co., received $2.3 million in funding from the Department of Defense to support the development of biologic- based monoclonal antibody therapies against biowarfare agents. Under the nine-month contract Morphotek will continue developing the therapies to treat Botulinum neurotoxins. "The further development of these compounds will enable us to advance these leads into clinical studies for validation and registration," says Nicholas Nicolaides, president and CEO of Morphotek.

Subscriber-only content. Please log in below.

Not a subscriber or registered user yet?

Please contact us at clientservices@accessintel.com or call us at 888-707-5814 (Monday – Thursday 9:00 a.m. – 5:30 p.m. and Friday 9:00 a.m. – 3:00 p.m. ET.), to start a free trial, get pricing information, order a reprint, or post an article link on your website.

Congress Updates

Fischer Says Golden Dome Boosters Need To Increase Capitol Hill Support With Information, Warns Against Counting On Reconciliation

NATIONAL HARBOR, Md. – A Senate Armed Services panel chair today said boosters of the Golden Dome program still have work to do to increase support on Capitol Hill while […]


HII Executive Outlines Its Shipbuilding Acceleration Strategy

An HII [HII] shipbuilding executive last week told lawmakers how the company plans to improve and accelerate shipbuilding throughout via workforce improvements, adding new shipbuilding infrastructure and reinforcing distributed shipbuilding […]


House Sends Dec. 11 CR With Ship Construction Funds To Trump’s Desk For Final Signature

The House on Tuesday passed a stopgap funding bill to keep the government open through Dec. 11, sending the temporary funding measure that also includes funds to support ongoing shipbuilding […]


Guetlein On Golden Dome: ‘We Cannot Protect This Nation And Bankrupt It At The Same Time’

While there has been criticism among missile defense advocates of Golden Dome’s development pace after the signing of an executive order in January last year, Space Force Gen. Michael Guetlein, […]